Human H2AFX/H2A.X/H2A/X ORF/cDNA clone-Lentivirus plasmid (NM_002105)
Cat. No.: pGMLP000507
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human H2AFX/H2A.X/H2A/X Lentiviral expression plasmid for H2AFX lentivirus packaging, H2AFX lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.
Our GM-Lentiviral vector is seamlessly integrated with the GM lentivirus packaging system. Discover more about the GM lentivirus packaging system.
Go to
Histone H2A.X/H2AX/H2AFX/H2AFX/H2A.X products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
| Catalog ID | pGMLP000507 |
| Gene Name | H2AFX |
| Accession Number | NM_002105 |
| Gene ID | 3014 |
| Species | Human |
| Product Type | Lentivirus plasmid (overexpression) |
| Insert Length | 432 bp |
| Gene Alias | H2A.X,H2A/X,H2AX |
| Fluorescent Reporter | ZsGreen |
| Mammalian Cell Selection | Puromyocin |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | CMV |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGTCGGGCCGCGGCAAGACTGGCGGCAAGGCCCGCGCCAAGGCCAAGTCGCGCTCGTCGCGCGCCGGCCTCCAGTTCCCAGTGGGCCGTGTACACCGGCTGCTGCGGAAGGGCCACTACGCCGAGCGCGTTGGCGCCGGCGCGCCAGTGTACCTGGCGGCAGTGCTGGAGTACCTCACCGCTGAGATCCTGGAGCTGGCGGGCAATGCGGCCCGCGACAACAAGAAGACGCGAATCATCCCCCGCCACCTGCAGCTGGCCATCCGCAACGACGAGGAGCTCAACAAGCTGCTGGGCGGCGTGACGATCGCCCAGGGAGGCGTCCTGCCCAACATCCAGGCCGTGCTGCTGCCCAAGAAGACCAGCGCCACCGTGGGGCCGAAGGCGCCCTCGGGCGGCAAGAAGGCCACCCAGGCCTCCCAGGAGTACTAA |
| ORF Protein Sequence | MSGRGKTGGKARAKAKSRSSRAGLQFPVGRVHRLLRKGHYAERVGAGAPVYLAAVLEYLTAEILELAGNAARDNKKTRIIPRHLQLAIRNDEELNKLLGGVTIAQGGVLPNIQAVLLPKKTSATVGPKAPSGGKKATQASQEY |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Target Antibody | GM-Tg-g-T55244-Ab | Anti-H2AFX monoclonal antibody |
| Target Antigen | GM-Tg-g-T55244-Ag | H2AFX protein |
| ORF Viral Vector | pGMLP000507 | Human H2AFX Lentivirus plasmid |
| ORF Viral Vector | pGMAP000115 | Human H2AFX Adenovirus plasmid |
| ORF Viral Vector | vGMLP000507 | Human H2AFX Lentivirus particle |
| ORF Viral Vector | vGMAP000115 | Human H2AFX Adenovirus particle |
Target information
| Target ID | GM-T55244 |
| Target Name | Histone H2A.X/H2AX/H2AFX |
|
Gene Group Identifier (Target Gene ID in Homo species) |
3014 |
| Gene ID |
101095127 (Felis catus), 111774230 (Equus caballus), 15270 (Mus musculus), 3014 (Homo sapiens) 489372 (Canis lupus familiaris), 500987 (Rattus norvegicus), 531733 (Bos taurus), 703073 (Macaca mulatta) |
| Gene Symbols & Synonyms | H2AX,H2ax,H2A.X,H2afx,Hist5-2ax,gammaH2ax,H2A/X,H2AFX,RGD1566119 |
| Target Alternative Names | H2A.X,H2A/X,H2AFX,H2AX,H2a/x,H2afx,H2ax,Hist5-2ax,Histone H2A.X,Histone H2AX,RGD1566119,gammaH2ax |
| Uniprot Accession |
P16104,P27661
Additional SwissProt Accessions: P27661,P16104 |
| Uniprot Entry Name | |
| Protein Sub-location | Introcelluar Protein |
| Category | Therapeutics Target |
| Disease | cancer |
| Disease from KEGG | |
| Gene Ensembl | ENSMUSG00000049932, ENSG00000188486, ENSCAFG00845000497, ENSBTAG00000067452, ENSMMUG00000044496 |
| Target Classification | Tumor-associated antigen (TAA) |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


